The first draft of a human pangenomic reference, which includes 47 individuals selected to maximize biogeographic diversity, offers a path to more accurate and effective screening for disease. This broader and more complete view of genetic diversity could lead to new targets for cancer therapies.

You do not currently have access to this content.